Results 241 to 250 of about 44,899 (264)

CYP2D6 Testing

2022
openaire   +1 more source

Interethnic variability ofCYP2D6alleles and of predicted and measured metabolic phenotypes across world populations

Expert Opinion on Drug Metabolism and Toxicology, 2014
Adrian Llerena, Fernanda Rodrigues-Soares, Eva M Penas-Lledo   +2 more
exaly  

Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites

Archives of Pharmacal Research, 2015
Ji-Yeong Byeon, Jong-Hwa Jang, Young-Hoon Kim   +2 more
exaly  

CYP2D6 and Tamoxifen: Awaiting the Denouement

Journal of Clinical Oncology, 2011
Hiltrud B, Brauch, Werner, Schroth, James N, Ingle, Matthew P, Goetz   +3 more
openaire   +2 more sources

Significantly lower CYP2D6 metabolism measured as the O/N‐desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients

British Journal of Clinical Pharmacology, 2019
Tore Haslemo, Erik Eliasson, Marin M Jukic   +2 more
exaly  

Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients

Journal of Clinical Pharmacology, 2010
Zeruesenay Desta, Anne Nguyen, James M Rae   +2 more
exaly  

A Review of the Important Role of CYP2D6 in Pharmacogenomics

Genes, 2020
Christopher Taylor, Ian Crosby, Vincent Yip   +2 more
exaly  

Interactions of amphetamine analogs with human liver CYP2D6

Biochemical Pharmacology, 1997
S V Otton, T Inaba, W Kalow
exaly  

Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine

Archives of Pharmacal Research, 2018
Ji-Yeong Byeon, Choong-Min Lee, Young-Hoon Kim   +2 more
exaly  

CYP2D7–2D6Hybrid Tandems: Identification of Novel CYP2D6 Duplication Arrangements and Implications for Phenotype Prediction

Pharmacogenomics, 2010
Andrea Gaedigk, Uwe Fuhr, Anick Berard   +2 more
exaly